An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.

NCT Number	NCT07724132
Lead Sponsor	University College, London Collaborators: National Institute for Health Research, United Kingdom, Imperial College London, UK Dementia Research Institute Ltd, Alzheimers Research UK
Conditions	Alzheimer's Disease (AD), Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer Disease Dementia
Enrollment	1,200 participants
Start Date	2026-07-24
Primary Completion	2031-03 (estimated)
Study Completion	2031-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-23